Microbix J (MBX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 304 | 302 | 241 | 291 | 264 |
| Accounts receivable | -219 | -289 | 194 | -572 | 2,061 |
| Other Working Capital | 2,299 | -1,655 | 94 | 63 | 1,541 |
| Other Operating Activity | -252 | 586 | -1,244 | 364 | -1,156 |
| Operating Cash Flow | $2,131 | $-1,056 | $-714 | $146 | $2,710 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -215 | -551 | -132 | -1,207 | -265 |
| Investing Cash Flow | $-215 | $-551 | $-132 | $-1,207 | $-265 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 1,291 | 217 | 0 | 0 |
| Debt Repayment | -73 | -74 | -80 | -88 | -588 |
| Common Stock Repurchased | -166 | -400 | -361 | N/A | N/A |
| Other Financing Activity | 11 | 87 | 8 | 474 | 105 |
| Financing Cash Flow | $-229 | $903 | $-217 | $386 | $-483 |
| Beginning Cash Position | 11,722 | 12,425 | 13,488 | 14,163 | 12,201 |
| End Cash Position | 13,409 | 11,722 | 12,425 | 13,488 | 14,163 |
| Net Cash Flow | $1,688 | $-704 | $-1,063 | $-675 | $1,962 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,131 | -1,056 | -714 | 146 | 2,710 |
| Capital Expenditure | -215 | -551 | -132 | -1,207 | -265 |
| Free Cash Flow | 1,916 | -1,607 | -846 | -1,061 | 2,445 |